▲乐普医疗申报的“聚乳酸面部填充剂”获NMPA批准上市(图源:NMPA)最新消息,乐普(北京)医疗器械股份有限公司(以下简称“乐普医疗”,股票代码:300003)申报的“聚乳酸面部填充剂”获NMPA批准上市,注册证编号:国械注准202523131101,产品适用于注射到鼻唇沟部位的真皮深层,以纠正中重度鼻唇沟皱纹。目前市场上主流的医美再生材料中,以PLLA/PDLLA为核心成分的称之为“童颜针”,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.